Unknown

Dataset Information

0

Adeno-associated Virus Serotype 9 - Driven Expression of BAG3 Improves Left Ventricular Function in Murine Hearts with Left Ventricular Dysfunction Secondary to a Myocardial Infarction.


ABSTRACT:

Objectives

The present study was undertaken to test the hypothesis that gene delivery of BCL2-Associated Athanogene 3 (BAG3) to the heart of mice with left ventricular dysfunction secondary to a myocardial infarction could enhance cardiac performance.

Background

BAG3 is a 575 amino acid protein that has pleotropic functions in the cell including pro-autophagy and anti-apoptosis. Mutations in BAG3 have been associated with both skeletal muscle dysfunction and familial dilated cardiomyopathy and BAG3 levels are diminished in non-familial heart failure.

Methods

Eight-week-old C57/BL6 mice underwent ligation of the left coronary artery (MI) or sham surgery (Sham). Eight weeks later, mice in both groups were randomly assigned to receive either a retro-orbital injection of rAAV9-BAG3 (MI-BAG3 or Sham-BAG3) or rAAV9-GFP (MI-GFP or Sham GFP). Mice were sacrificed at 3 weeks post-injection and myocytes were isolated from the left ventricle.

Results

MI-BAG3 mice demonstrated a significantly (p < 0.0001) higher left ventricular ejection fraction (LVEF) 9 days after rAAV9-BAG3 injection with further improvement in LVEF, fractional shortening and stroke volume at 3 weeks post-injection without changes in LV mass or LV volume. Injection of rAAV9-BAG3 had no effect on LVEF in Sham mice. The salutary benefits of rAAV9-BAG3 were also observed in myocytes isolated from MI hearts including improved cell shortening (p<0.05), increased systolic [Ca2+]i, increased [Ca2+]i transient amplitudes and increased maximal ICa amplitude.

Implications

The results suggest that BAG3 gene therapy may provide a novel therapeutic option for the treatment of heart failure.

SUBMITTER: Knezevic T 

PROVIDER: S-EPMC5289821 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adeno-associated Virus Serotype 9 - Driven Expression of BAG3 Improves Left Ventricular Function in Murine Hearts with Left Ventricular Dysfunction Secondary to a Myocardial Infarction.

Knezevic Tijana T   Myers Valerie D VD   Su Feifei F   Wang JuFang J   Song Jianliang J   Zhang Xue-Qian XQ   Gao Erhe E   Gao Guofeng G   Muniswamy Madesh M   Gupta Manish K MK   Gordon Jennifer J   Weiner Kristen N KN   Rabinowitz Joseph J   Ramsey Frederick V FV   Tilley Douglas G DG   Khalili Kamel K   Cheung Joseph Y JY   Feldman Arthur M AM  

JACC. Basic to translational science 20161201 7


<h4>Objectives</h4>The present study was undertaken to test the hypothesis that gene delivery of BCL2-Associated Athanogene 3 (BAG3) to the heart of mice with left ventricular dysfunction secondary to a myocardial infarction could enhance cardiac performance.<h4>Background</h4>BAG3 is a 575 amino acid protein that has pleotropic functions in the cell including pro-autophagy and anti-apoptosis. Mutations in BAG3 have been associated with both skeletal muscle dysfunction and familial dilated cardi  ...[more]

Similar Datasets

| S-EPMC6893492 | biostudies-literature
| S-EPMC1767522 | biostudies-literature
| S-EPMC3345143 | biostudies-literature
| S-EPMC6287443 | biostudies-literature
| S-EPMC6208878 | biostudies-literature
2006-07-13 | E-GEOD-4648 | biostudies-arrayexpress
| S-EPMC6426050 | biostudies-literature
| S-EPMC3331637 | biostudies-other
| S-EPMC5539273 | biostudies-other
| S-EPMC8310941 | biostudies-literature